‘Zombie cancer cells' in kids can evade chemo but scientists may have found solution
Scientists may have found a way to beat 'zombie cancer cells' - a type of cell that can survive chemotherapy. These evasive cells are more common in children, and are a major reason that cancer is the leading cause of disease-related death in childhood.
There are around 250 cancer deaths in children in the UK every year, that's around five every week, according to Cancer Research UK's data from 2017-2019. Brain tumours are one of the most common causes of cancer death in children, but the new scientific findings aim to tackle this.
Cancer poses a larger mortality risk to children with a type of gene called oncogenes, which are found inside the DNA of tumour cells. These cancer cells can lie dormant in the body after chemotherapy treatment while other cancer cells are killed. But they can then reactivate years later, causing the cancer to come back.
An international team of scientists published findings on August 7 in Cancer Discovery, which examined why a common form of pediatric nerve cell cancer called neuroblastoma is often treated successfully with chemotherapy, but prone to relapse in several years.
They discovered that tumour cells with fewer copies of the MYCNoncogene enter a zombie-like state known as senescence, where they persist but no longer divide to make new cells.
These 'zombie cells' are unaffected by chemotherapy and can be reactivated a year or two later, triggering the cancer to relapse.
But the researchers may be on the way to finding a solution to killing these durable cancer cells, after finding a way to target them in mice.
The researchers found that combining standard chemotherapy with another secondary therapy which is able to target senescent cancer cells led to dramatically improved outcomes in tests on mouse models of neuroblastoma.
Lukas Chavez, PhD, is an associate professor in the Cancer Genome and Epigenetics Program at Sanford Burnham Prebys, and co-author of the study.
Chavez said: "We have shown that these ecDNAs [which cause zombie cells] are much more abundant in solid pediatric tumours than we previously thought.
'And we have also shown that they are associated with very poor outcomes."
However, the scientist added that their findings hold potential to dramatically increase the outcomes for human child patients, though more research is needed.
Chavez continued: "By integrating genomic analyses of tumour DNA with hypothesis-driven functional experiments and high-throughput drug screening, we aim to discover new drugs and drug combinations that halt tumour growth by eliminating these oncogenic DNA circles.
'Ultimately, our goal is to translate these scientific advances into more effective therapies and lasting cures for children with brain cancer.'
Ashley Hui, a graduate student in Chavez's lab, contributed to this study by showing that zombie cells with low amounts of ecDNA carrying MYCN [an oncogene] can also be observed in medulloblastoma, the most common brain tumour type in children.
While more research is required, the scientists are hopeful their findings will lead to more effective cancer treatment for children.
Join the Daily Record WhatsApp community!
Get the latest news sent straight to your messages by joining our WhatsApp community today.
You'll receive daily updates on breaking news as well as the top headlines across Scotland.
No one will be able to see who is signed up and no one can send messages except the Daily Record team.
All you have to do is click here if you're on mobile, select 'Join Community' and you're in!
If you're on a desktop, simply scan the QR code above with your phone and click 'Join Community'.
We also treat our community members to special offers, promotions, and adverts from us and our partners. If you don't like our community, you can check out any time you like.
To leave our community click on the name at the top of your screen and choose 'exit group'.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Record
13 hours ago
- Daily Record
‘Zombie cancer cells' in kids can evade chemo but scientists may have found solution
These cancer cells can lie dormant in children, before reactivating later and causing the patient to relapse. Scientists may have found a way to beat 'zombie cancer cells' - a type of cell that can survive chemotherapy. These evasive cells are more common in children, and are a major reason that cancer is the leading cause of disease-related death in childhood. There are around 250 cancer deaths in children in the UK every year, that's around five every week, according to Cancer Research UK's data from 2017-2019. Brain tumours are one of the most common causes of cancer death in children, but the new scientific findings aim to tackle this. Cancer poses a larger mortality risk to children with a type of gene called oncogenes, which are found inside the DNA of tumour cells. These cancer cells can lie dormant in the body after chemotherapy treatment while other cancer cells are killed. But they can then reactivate years later, causing the cancer to come back. An international team of scientists published findings on August 7 in Cancer Discovery, which examined why a common form of pediatric nerve cell cancer called neuroblastoma is often treated successfully with chemotherapy, but prone to relapse in several years. They discovered that tumour cells with fewer copies of the MYCNoncogene enter a zombie-like state known as senescence, where they persist but no longer divide to make new cells. These 'zombie cells' are unaffected by chemotherapy and can be reactivated a year or two later, triggering the cancer to relapse. But the researchers may be on the way to finding a solution to killing these durable cancer cells, after finding a way to target them in mice. The researchers found that combining standard chemotherapy with another secondary therapy which is able to target senescent cancer cells led to dramatically improved outcomes in tests on mouse models of neuroblastoma. Lukas Chavez, PhD, is an associate professor in the Cancer Genome and Epigenetics Program at Sanford Burnham Prebys, and co-author of the study. Chavez said: "We have shown that these ecDNAs [which cause zombie cells] are much more abundant in solid pediatric tumours than we previously thought. 'And we have also shown that they are associated with very poor outcomes." However, the scientist added that their findings hold potential to dramatically increase the outcomes for human child patients, though more research is needed. Chavez continued: "By integrating genomic analyses of tumour DNA with hypothesis-driven functional experiments and high-throughput drug screening, we aim to discover new drugs and drug combinations that halt tumour growth by eliminating these oncogenic DNA circles. 'Ultimately, our goal is to translate these scientific advances into more effective therapies and lasting cures for children with brain cancer.' Ashley Hui, a graduate student in Chavez's lab, contributed to this study by showing that zombie cells with low amounts of ecDNA carrying MYCN [an oncogene] can also be observed in medulloblastoma, the most common brain tumour type in children. While more research is required, the scientists are hopeful their findings will lead to more effective cancer treatment for children. Join the Daily Record WhatsApp community! Get the latest news sent straight to your messages by joining our WhatsApp community today. You'll receive daily updates on breaking news as well as the top headlines across Scotland. No one will be able to see who is signed up and no one can send messages except the Daily Record team. All you have to do is click here if you're on mobile, select 'Join Community' and you're in! If you're on a desktop, simply scan the QR code above with your phone and click 'Join Community'. We also treat our community members to special offers, promotions, and adverts from us and our partners. If you don't like our community, you can check out any time you like. To leave our community click on the name at the top of your screen and choose 'exit group'.
The Independent
2 days ago
- The Independent
Significant disparities in survival rates found across cancer types
A new study reveals that progress in cancer survival rates across the UK has "slowed down", with the disparity between the most and least deadly forms of the disease widening. The comprehensive research, led by the London School of Hygiene and Tropical Medicine and funded by Cancer Research UK, analysed long-term trends from 1971 to 2018 for millions of adults in England and Wales. While the 10-year cancer survival index reached 49.8 per cent in 2018, the rate of improvement has declined sharply, from a 4 per cent rise between 2000 and 2005 to just 1.4 per cent between 2010 and 2015. Significant disparities persist across cancer types, with 10-year survival for testicular cancer at 97 per cent, contrasting sharply with only 4.3 per cent for pancreatic cancer, indicating a system-wide challenge. Experts, including Cancer Research UK, are urgently calling for a national cancer plan to address delays, improve early diagnosis, and boost screening programmes to reverse this concerning trend.
Wales Online
2 days ago
- Wales Online
Speed of improvement in cancer survival rates ‘slowing', say experts
Speed of improvement in cancer survival rates 'slowing', say experts The news comes as a study suggests survival between the most and least deadly types of the disease is wider than ever before. (Image: PA) Progress in cancer survival rates in the UK has "slowed down", experts have warned. The news comes as a study suggests survival between the most and least deadly types of the disease is wider than ever before. A national cancer plan was "essential" to "bring cancer survival trends back towards the best in the world", researchers said. The study, led by the London School of Hygiene and Tropical Medicine (LSHTM) and funded by Cancer Research UK, analysed long-term trends in the cancer survival index (CSI) for adults across England and Wales from 1971 to 2018. Using records from the National Disease Registration Service for England and the Welsh Cancer Intelligence and Surveillance Unit, experts estimated net survival for up to 10 years after diagnosis for around 10.8 million people. They found that in 2018, the CSI for all cancers combined a decade after diagnosis was 49.8%, higher than the CSI at one year for those diagnosed in 1971/72. Researchers hailed the figure as "remarkable", but warned that the "speed of improvement in survival has slowed down". In the five years from 2000/01 to 2005/06, the 10-year CSI rose by 4%, from 41.2% to 45.2%. But between 2010/11 and 2015/16, the rise was 1.4%, from 47.9% to 49.3%. There were also major gaps in survival when it came to different cancer types. For example, 10-year survival for testicular cancer was 97%, compared with 4.3% for pancreatic cancer. Screening programmes had bolstered survival rates for cancers in the breast, bowel and cervix, according to Cancer Research UK. But survival for other types, such as stomach, lung and brain cancer, had increased by only a small amount in the past 50 years. Writing in the Lancet Regional Health – Europe, researchers warned this slowdown for individual cancers implied a "system-wide challenge". Michelle Mitchell, chief executive of Cancer Research UK, said: "Thanks to research, most patients today are far more likely to survive their cancer than at any point in the past. "But the reality is that this progress is slowing – and for some cancers, it never got going in the first place." The Government launched a call for evidence to help shape a national cancer plan in February. The blueprint aims to outline actions to transform how the disease is treated in a bid to reduce deaths. Ms Mitchell said: "The upcoming National Cancer Plan for England must include commitments to spot more cancers earlier, as well as backing research into new treatments so that each patient, regardless of their diagnosis, can hope for more moments with the people they love." Michel Coleman, a professor of epidemiology and statistics at LSHTM, said: "Since I began my career in cancer research, I've seen substantial increases in survival for most types of cancer. "Our understanding of cancer biology has expanded, effective screening programmes have been introduced, and new treatments have been developed. Allowing this trend to stall will have devastating consequences. "This study was only possible because of data on millions of patients from cancer registries in England and Wales. "It's vital that the Government provides the political and financial support to ensure we maintain this crucial data. Without these, the Government will be flying blind on cancer control. "The National Cancer Plan is a chance to improve NHS cancer pathways and reap the benefits of new research – the Government must take it." Cancer Research UK is calling for the national cancer plan to slash waiting times for diagnosis and treatment, saying some patients face unacceptable delays. The plan should also improve early diagnosis of cancer, with plans to boost participation in existing screening programmes and a commitment to rolling out lung cancer screening fully in England by 2029. A Department of Health and Social Care spokesperson said: "We are prioritising cancer care as we turn around more than a decade of neglect of our NHS. Article continues below "We're already seeing progress, with 95,000 more people having cancer diagnosed or ruled out within 28 days between July 2024 and May 2025, compared to the same period the previous year. "The National Cancer Plan will set out how we will improve survival rates further and address the variation between different cancer types."
